CompletedPhase 2NCT00002903
Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer
Studying Extragonadal germ cell tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Principal Investigator
- Emma Geertruida Elisabeth De Vries, MD, PhD, MD PhDUniversity Medical Center Groningen
- Intervention
- docetaxel(drug)
- Enrollment
- 25 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 1995
Study locations (30)
- Ludwig Boltzmann - Institute for Applied Cancer Research, Vienna, Austria
- Institut Jules Bordet, Brussels, Belgium
- Universitair Ziekenhuis Antwerpen, Edegem, Belgium
- U.Z. Gasthuisberg, Leuven, Belgium
- Rigshospitalet, Copenhagen, Denmark
- Herlev Hospital - University Hospital of Copenhagen, Herlev, Denmark
- Institut Bergonie, Bordeaux, France
- Centre Jean Perrin, Clermont-Ferrand, France
- Centre de Lute Contre le Cancer,Georges-Francois Leclerc, Dijon, France
- Centre Oscar Lambret, Lille, France
- Centre Leon Berard, Lyon, France
- CHU de la Timone, Marseille, France
- CRLCC Nantes - Atlantique, Nantes-Saint Herblain, France
- Institut Curie - Section Medicale, Paris, France
- Centre Eugene Marquis, Rennes, France
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00002903 on ClinicalTrials.govOther trials for Extragonadal germ cell tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06418789High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell TumorsN.N. Petrov National Medical Research Center of Oncology
- RECRUITINGPHASE3NCT03067181Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell TumorsChildren's Oncology Group
- ACTIVE NOT RECRUITINGPHASE3NCT02375204Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell TumorsAlliance for Clinical Trials in Oncology